Pharmacodynamics and tolerability of DT-TX 30 SE, a novel combined TXA 2/PGH 2 receptor blocker and thromboxane synthetase inhibitor, in healthy volunteers

Saved in:
Bibliographic Details
Published inFibrinolysis Vol. 8; p. 76
Main Authors Narjes, H., Müller, T.H., Weisenberger, H., Kirchner, M., Deichsel, G.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 1994
Online AccessGet full text

Cover

More Information
ISSN:0268-9499
DOI:10.1016/0268-9499(94)90494-4